Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.008 AUD | 0.00% | -11.11% | 0.00% |
Apr. 10 | Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment | MT |
Feb. 23 | Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 3.33M 2.19M | Sales 2023 | 2.85M 1.88M | Capitalization | 20.57M 13.54M |
---|---|---|---|---|---|
Net income 2022 | -6M -3.95M | Net income 2023 | -7M -4.61M | EV / Sales 2022 | 9.39 x |
Net cash position 2022 | 9.82M 6.46M | Net cash position 2023 | 4.05M 2.66M | EV / Sales 2023 | 5.8 x |
P/E ratio 2022 |
-5.78
x | P/E ratio 2023 |
-2.91
x | Employees | 10 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.29% |
1 week | -11.11% | ||
Current month | -11.11% | ||
1 month | -15.79% | ||
3 months | -11.11% |
Managers | Title | Age | Since |
---|---|---|---|
James Campbell
CEO | Chief Executive Officer | - | 14-11-11 |
Chief Tech/Sci/R&D Officer | - | 12-05-31 | |
Rebecca Tunstall
PRN | Corporate Officer/Principal | - | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pamela Klein
BRD | Director/Board Member | 63 | 19-09-30 |
James Campbell
CEO | Chief Executive Officer | - | 14-11-11 |
Michael Stork
BRD | Director/Board Member | - | 07-02-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.008 | 0.00% | 1 167 200 |
24-05-02 | 0.008 | 0.00% | 2,758,291 |
24-05-01 | 0.008 | -11.11% | 7,368 |
24-04-30 | 0.009 | 0.00% | 1,150,821 |
24-04-29 | 0.009 | 0.00% | 469,879 |
Delayed Quote Australian S.E., May 03, 2024 at 01:05 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 10.76M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+46.79% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- PAB Stock